Regeneron Pharmaceuticals, Inc.
Anti-TMPRSS2 antibodies and antigen-binding fragments

Last updated:

Abstract:

The present invention includes an antibody or antigen-binding fragment thereof that binds specifically to TMPRSS2 and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., influenza virus infections).

Status:
Grant
Type:

Utility

Filling date:

24 Jan 2019

Issue date:

9 Mar 2021